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The graft-vs.-host (GVH) 1 reaction has proved to be a very useful means of meas- 
uring the immunological reactivity of lymphoid cells  to histocompatibility antigens. 
A  variety  of methods  has  been  developed  for quantitating  this  reaction.  They in- 
clude:  (a)  death  or wasting  syndromes in immunologically defenseless  hosts  (1-4), 
(b)  the  discriminate  spleen assay  (5),  (c)  splenomegaly in immunologically defense- 
less adult hosts (6),  (d) chorioallantoic membrane (CAM) assay (7),  (e) phagocytosis 
assay  (8),  (f)  liver  infiltration  assay  (9),  (g)  local lymphocyte infiltration  assay  in 
skin (10) or kidney (11) after local injection of donor cells, and (h) an in vitro assay 
(12).  More  recently,  Ford et  al.  (13,  14)  and Yoshida  and  Osmond  (15)  have  de- 
veloped a very sensitive GVH assay in rats, based on the observation of Levine (16) 
that when parental strain lymphoid cells are injected into the feet of F1 hybrid hosts, 
the draining popliteal lymph nodes enlarge.  This assay, with a  number of modifica- 
tions,  has  been adapted  for use  in mice by Hardt  and  Clafisson  (17).  All of these 
methods,  with  the  exception of the  CAM assay and several studies  specifically  de- 
signed to measure donor cell proliferation directly (18,  19), measure GVH indirectly; 
i.e.,  they measure primarily the host's response to the  GVH reaction. 
In the most widely used of these assays, the discriminant spleen assay, the mecha- 
nism of splenomegaly has been extensively studied.  Cytogenetic analyses of the pro- 
liferating cells in the enlarging host spleen clearly indicate that most of the proliferat- 
ing cells  are  of host rather  than donor origin  (20).  These findings are supported by 
studies in which previous irradiation of the  host has been shown to inhibit the  sub- 
sequent  development of splenomegaly (21).  The  role of nondividing cells  in  GVH- 
induced splenomegaly, however, has not been investigated. 
Recent  evidence  has  indicated  that  a  large  part  of  the  splenomegaly  and 
lymphadenopathy resulting from ordinary antigenic stimulation is the result of 
the  trapping  of recirculating lymphocytes in the spleen  and the lymph nodes, 
respectively (22-27). In the experiments to be described we have demonstrated 
that  a  major  portion  of  the  lymphadenopathy  in  the  local  GVH  reaction  in 
mice is similarly due to the trapping of recirculating lymphoid cells. 
* This study was supported  by Grants  AI-09106, GRS-5501-RR 05398, and ACS-IN-96 
from the U.S. Public Health Service, National  Institutes of Health. 
1 Abbreviations used in this paper: BAFI, C57BL/6  X A/J F1 mice; CAM, chorioallantoic 
membrane;  GIBCO,  Grand  Island  Biological Co.;  GVH,  graft-vs.-host;  HBSS,  Hanks' 
balanced salt solution; TC-199, tissue culture medium 199. 
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Experimental Design.--Graded  doses of parental spleen or lymph node cells were injected 
into the right rear footpads of F1 hybrid hosts. At 2-7-day intervals,  the weights, the trap- 
ping of passively transferred ~lCr-labeled syngeneic spleen cells, and the uptake of  [14C]thy- 
mldine by the right popliteal lymph nodes were determined. The left popliteal lymph nodes 
of the same mice  (or other mice),  challenged with a  similar dose of syngeneic cells or with 
physiologic saline, were studied in  the same way for comparison.  Groups of four mice were 
employed for each cell dose in each experiment, and doses were graded in the ratio 125:25:5:1. 
Animals.--Young,  adult,  female  (6-12-wk-old)  A/J  mice were used  as  the donor strain, 
and  C57BL/6  X  A/J  lVl (BAF1)  female mice of a  similar age were used as the host strain. 
They were purchased from the Jackson Laboratory, Bar Harbor, Maine. 
Preparation U" Cell Suspensions for Inoculation.--Suspensions  of spleen and  lymph node 
cells were prepared as previously described (27).  In brief,  they were minced in  Hanks'  bal- 
anced  salt  solution  (HBSS)  and  passed  through  a  series  of graded  stainless  steel  screens. 
After cell counts and standard  trypan blue viability tests in Sahli hemacytometers, the cells 
were resuspended in a volume of HBSS so as to give 10.0  X  106 viable cells in a 20-~1 volume 
(20 #1 is the maximum volume that can be given intracutaneously into the rear footpad of a 
20-25-g mouse). Two footpad injections, separated by 15 min, were required to get the maxi- 
mum dose of 20.0  X  106 cells into the footpad. 
Fool Injectlons.--The cell suspensions were taken  up in  a  100-#l  Hamilton syringe fitted 
with a  27-gauge needle. To inject the cells, the needle was inserted through the skin between 
the first and  second digits and  pushed  into the  loose subcutaneous  space in  the  middle of 
the foot. 
Labding  of Spleen Cells with 51Cr.--BAF1 spleen cells were suspended at a  concentration 
of 5.0  X  107  cells/ml in  tissue culture medium  199  (TC-199)  (Grand  Island  Biological Co. 
[GIBCO],  Grand  Island,  N.  V.)  containing 75  #Ci/ml  of  sodium  chromate  ~lCr  (Abbott 
Radio  Pharmaceuticals,  Chicago,  Ill.),  15%  IPT  gamma  globulin  free  fetal  calf  seruna 
(GIBCO),  100 IU/ml of penicillin, and 100 ~g/ml of streptomycin, and incubated for 45 min 
in a humidified atmosphere of 5% CO2 and 95% air. Excess SlCr was removed by three washes 
with 50 ml of TC-199 containing 15% fetal calf serum. The cells were then passed through a 
200~mesh stainless steel strainer, and 0.25-ml samples (containing 1.0  X  10  ~ nucleated cells) 
were given intravenously to the hosts 24 h  before sacrifice. 
Radioactive Thymidim  Incorporation in Lymph  Nodes.--Host  mice  were  given  5  #CI  of 
[I4C]thymidine intravenously and sacrificed exactly 2 h  later. 
Weights  and  Radiochemicat Determinations.--After  sacrifice,  the  host's  popliteal  lymph 
nodes were removed and carefully freed of fat. They were then washed and dehydrated with 
three daily changes of acetone, air-dried, weighed on  a  Mettler semimicrobalance  (Mettler 
Instrument Corp., Princeton, N. J.)  to an accuracy of 0.01  mg, and dissolved in 0.5 ml of N 
NaOH.  Those  labeled  with  [14C]thymidine  were  incorporated  into  a  Cab-O-Sil  cocktail 
(Packard Instrument Co., Inc., Downers Grove, Ill.) and  counted in a  Tri-Carb  Liquid Scin- 
tillation  Counter  (Packard  model 3375,  Packard  Instrument  Co.,  Inc.),  as  previously  de- 
scribed (27). Those labeled with 51Cr were counted in a  well-type scintillation counter. 
Analysis o[ Data.~The geometric means of the weights and counts per minute of the lymph 
nodes corresponding to each dose level were determined and plotted against the dose on double- 
log scales. When dose-response relationships were approximately linear, lines of best fit over 
that dose range were determined by the least square method  (28).  To test the hypothesis of 
linearity  of  regression,  an  analysis  of  variance  technique  comparing  the  variance  within 
groups with the variance of the deviations of the group means from the estimated regression 
line was used (29). The hypothesis of ]inearity of regression was rejected when the calculated 
F  ratio exceeded the table F  value using an c~ of 0.05.  Differences in the means of individual 
experiments were evaluated statisticalIy by the Student's t test (30).  In the experiments con- 
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those of the other days by expressing  them as a  percentage of the counts per minute of a 
sample of the donor pool. 
RESULTS 
The data relating the weights of stimulated nodes to dose of donor cells are 
shown  in  Table  I.  The  geometric  mean  weight  of  20  normal  unstimulated 
popliteal  lymph  nodes  in  6-12-wk-old  female BAF1  mice  was 0.21  mg  4-  a 
standard error of the mean (SE) of 0.02 (range 0.10-0.30 rag). The mean weights 
of unstimulated popliteal nodes of mice 6 days after the injection of A/J spleen 
cells into the contralateral footpads showed a slight but statistically insignificant 
(P  >  0.01)  enlargement.  6  days  after  challenge  by  syngeneic  BAF1  cells, 
popliteal nodes also showed a slight degree of enlargement, which is statistically 
significant (P <  0.01) at a dose of 20.0  X  106 donor cells. With parental (A/J) 
cells,  as in  studies in rats (13-15),  there is a  linear dose-response relationship 
over a range of 0.8  M  106-20  N  106 for days 3-6 when plotted on a double-log 
scale. This is shown graphically for days 4 and 6 in Fig. 1.6 days after the injec- 
tion of the parental  cells,  the popliteal  lymph nodes  were seven to  nine  times 
heavier than  the nodes of uninjected  controls.  In three  additional  experiments 
(data not given)  in which  a  similar range of doses of donor cells was  used,  the 
linear dose-response relationships for days 3-6 were almost identical with those 
seen in Fig.  1. 
Trapping of ~lCr-Labeled  Lymphoid Cells.--The data relating the trapping of 
labeled  BAF1 lymphocytes  in  challenged lymph nodes  during  days  2,  4,  and  6 
TABLE I 
Mean Weights (±SE) of PopIiteal Lymph Nodes of BA F1 Mice after Injection of A/J Spleen 
Cells, BAF1 Spleen  Cells, or  No  Cells into Rear  Footpads 
Day 
0 
2 
3 
4 
5 
6 
6:~ 
6§ 
7 
0.16 
Dose X  10  6 
0.21  4-  0.02  (20)* 
0.26  4-  0.01  (4) 
0.28  4-  0.07  (4) 
0.31  ±  0.04  (3) 
0,25  4-  0.06  (4) 
0.27  4-  0.07  (4) 
0.22  4-  0.03  (4) 
0.29  ±  0.09  (4) 
0.20  4-  0.07  (4) 
0.8 
mg 
0.35  4- 0,02  (4) 
0.24  4-  0.04  (4) 
0.28  ±  0.08  (4) 
0.37  4-  0.01  (4) 
0.38  ±  0.12  (3) 
0.24  4- 0.05  (4) 
0.27  4-  0.03  (4) 
0.40  ±  0.10  (4) 
4.0 
0.28  ±  0.02  (4) 
0.35  4-  0.13  (3) 
0.61  4-  0.07  (4) 
0.78  4-  0.35  (4) 
0.73  4-  0.10  (4) 
0.32  ±  0.07  (4) 
0.31  ±  0.07  (4) 
0.57  4-  0.08  (4) 
20.0 
E 
0.45  +  0.08  (4) 
0.82  4-  0.09  (4) 
1.30  ±  0.06  (4) 
1.26  4-  0.13  (4) 
1.76  4-  0.09  (4) 
0.31  4-  0.04  (4) 
0.39  4-  0.04  (4) 
1.67  ±  0.36  (4) 
* Values in parentheses indicate the number of animals. 
:~ Mean weights of unstimulated popliteal lymph nodes of BAF1 mice 6 days after the in- 
jection of A/J (allogeneic)  spleen cells into the contralateral  footpads. 
§ Mean  weights  of popliteal lymph nodes  of BAF1 mice 6  days  after  the  injection of 
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to  the  dose  of A/J  donor  ceils are  given  in  Table  I1.  There  was  significant 
(P  <  0.01)  trapping of recirculating cells within 2 days of the initiation of the 
GVH  reaction with  the highest dose. Within 4  days, lymph nodes challenged 
with this same dose of A/J cells were trapping BAF1 lymphocytes at seven times 
the normal rate. Trapping was still occurring on day 6, but at a  somewhat re- 
duced rate. These data are shown graphically in Fig. 2. The dose-response re- 
lationship is not linear when plotted individually for days 2, 4, and 6. However, 
when the total accumulation of trapped cells over the 6-day period is estimated, 
by normalizing and summing the accumulation of days 2, 4, and 6, the double- 
log plot is linear. 
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FIG. 1.  Dose-response graph of the mean weights  of the popliteal lymph nodes of BAF1 
mice 2 (X), 4 (O), and 6 (A) days after injection of A/J spleen cells into the rear footpads. 
TABLE II 
Mean Counts per Minute  (4-SE)  of 5ZCr-Labeled BAFx Spleen Cdls Trapped in the Popliteal 
Lymph Nodes of BAF1 Mice, 2, 4, and 6 Days after Injection of A/a  r Spleen Cells into 
Rear Footpads 
Doses X  106 
Day 
0.16  0.8  4.0  20.0 
0 
2 
4 
6 
Net~ 
259  4- 31  (22)* 
297  4-  10  (3) 
355  4-  45  (4) 
297  4-  83  (4) 
949 
349  ±  89  (4) 
541  4- 47  (4) 
753  4-  146  (4) 
1,643 
340  4-  137  (3) 
1,543  4-  144  (4) 
830  4-  30  (4) 
2,713 
990  ±  193  (3) 
1,982  4-  78  (4) 
1,269  4-  283  (4) 
4,241 
* Values in parentheses indicate the number of animals. 
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[14C]Thymidine  Uptake.--The  data relating [14C]thymidine uptake in counts 
per minute to the dose of parental cells 2, 4, and 6 days after the challenge are 
shown in Table III. In these experiments it was not possible to differentiate be- 
tween the thymidine taken up by host and donor cells. There is a  significant 
(P  <  0.01)  increase in thymidine uptake within 2 days of the initiation of the 
GVH reaction with the highest dose. This increase in thymidine uptake is 8-11 
times that in unstimulated nodes at day 6. When these data are plotted on a 
double-log scale (Fig. 3), there is a linear response from 0.16 to 20.0  )<  106 cells 
at day 6  and from'0.8 to 20.0  X  106 cells at day 4. 
The  times  of  onset  of  all  three  responses,  i.e.  increased  weight,  increased 
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FIG. 2.  Dose-response graph of the mean counts per minute of 51Cr-labeled BAFz spleen 
cells trapped in the popliteal lymph nodes of BAFz mice 2 (X), 4 (O), and 6 (A) days after 
injection of A/J spleen cells into rear footpads.  Each point (E3) on the highest slope repre- 
sents the sum of the geometric means of days 2, 4, and 6 (i.e., net accumulation).  All mice 
received their respective portions of 51Cr-labeled spleen cells 24 h before sacrifice. 
TABLE III 
Mean Counts per Minute  (:kSE) of 14C in the Popliteal Lymph Nodes of BAF1 Mice Z, 4, and 
6 Days after Injection of A/J Spleen Cells into Rear Footpads 
Dose X  10 6 
Day 
0.16  0.8  4.0  20.0 
0  193  4-  15  (4)*  --  --  -- 
2  188  4-  18  (4)  255  4-  16  (4)  237  ±  35  (4)  379:1:42  (4) 
4  183  -4-  12  (3)  229  4-  58  (4)  705  A: 78  (4)  1,800  4-  102  (4) 
6  176  4-  73  (3)  331  +  146  (4)  891  A: 109  (3)  1,941  4-  ltl  (3) 
* Values in parentheses indicate the number of animals. 3,000 
2,000 
r~ 
MECHANISM  OF  GVH-INDUCED  LYMPHADENOPATHY  IN  MICE 
1,000 
500 
4001 
300 
200 
o 
x 
1298 
I00  "--'//-  ,  J 
0.16  0.8  4,0  20,0 
CELL DOSE X I0  e 
FIO. 3.  Dose-response  graph of the counts per minute of 14C in the popliteal lymph nodes 
of BAFI mice 2 (X), 4 (C)), and 6 (A) days  after injection of A/J spleen cells into rear foot- 
pads. 5 #Ci of [14C]thymidine  were given intravenously to each mouse 2 h before sacrifice. 
trapping, and increased thymidine uptake, vary inversely with the dose of the 
parental cells used to initiate the reaction. 
DISCUSSION 
The present  experiments  clearly show that  there  is  a  selective  trapping  of 
51Cr-labeled syngeneic lymphoid cells in lymph nodes subjected to a local GVH 
reaction. It is reasonable to assume that this is accompanied by a  comparable 
selective trapping of the hosts'  own unlabeled recirculating lymphocytes. The 
results of these experiments do not permit us to state the exact fraction of the 
observed lymph node enlargement that is related to trapping, although evidence 
that recirculating cells in  transit make up a large part of the total cellularity of 
lymph nodes (31-33) makes it highly probable that trapping is a major factor. 
Proliferation of host cells within the reacting lymph node accounts for most of 
the  remaining  enlargement;  proliferation  of  donor  parental  strain  cells  pre- 
sumably contributes very little  to the lymph node enlargement,  inasmuch  as 
very few donor cells reach the node (13). 
Since the majority of the lymphocytes of the recirculating pool are long-lived 
(34),  and since short-lived cells  have little tendency to localize in lymph nodes 
(even with antigenic stimulation), 2 we assume that most of the 1)~mphoid cells 
trapped during the  GVH reaction  are  long-lived.  The present  studies  do not 
provide any information as to whether these are long-lived T  cells,  B cells,  or 
both (35). 
2 Emeson, E. E., D. R. Thursh, and T. Nobel. The partitioning of long- and short-lived 
lymphocytes in the lesions of cell-mediated hypersensitivity and their draining lymph nodes. 
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In lymph nodes subjected to conventional antigenic stimulation, most of the 
enlargement occurs within the first 24 h, a  time period before there are sub- 
stantial changes in lymph node DNA, RNA, or protein synthesis (36, 37). This 
suggests that most of the enlargement is due to lymphocyte trapping. There are 
at least two different mechanisms whereby this trapping of lymphocytes occurs. 
One  is  related  to  the  immunological  specificity of  the  lymphocytes being 
trapped (26, 27) ; the other is not (23, 26, 27, 38). The local GVH reaction seems 
to be an ideal model for the  study of this latter mechanism because, with one 
possible exception (39)  the F1 host is totally lacking in cells  that have  spe- 
cific immunological reactivity toward any of the parental strain antigens. 
Although the trapping of specifically reactive lymphocytes can be projected 
as a mechanism for concentrating specific cells in a local lymph node to amplify 
the immune response, the significance of the trapping of cells lacking in spec- 
ificity is not as readily inferred. It is tempting, however, to speculate that this 
nonspecific trapping of lymphocytes plays a role in the action of adjuvants (23, 
24, 37), in the "allogeneic effect" described by Katz and Osborne (40, 41)  and 
in the abrogation of tolerance to sheep erythrocytes by means of transferring 
allogeneic lymphocytes described by McCullagh (42).  The studies of O'Toole 
and Davies (43) suggest that nonspecific trapping may be a factor in antigenic 
competition as well. 
Finally, the present studies, along with those of Hardt and Clafisson  (17), 
have shown that the popliteal lymph node GVH assay described initially in the 
rat (13-15)  can be used in the mouse and shows a similar cell dose dependency. 
Although the smaller size of mouse footpads and popliteal lymph nodes does 
present minor technical difficulties, they are balanced by the wider variety and 
greater availability of inbred strains of this species available for study. 
SUMMARY 
Graft-vs.-host (GVH)-induced lymphadenopathy  of the popliteal lymph node 
has been produced in C57BL/6 X  A/J F1 (BAF1) mice by injecting A/J spleen 
cells into the rear footpads. By giving ~lCr-labeled BAF1 lymphoid cells intra- 
venously to the hosts, 24 h before sacrifice, we have demonstrated that a large 
portion of the GVH-induced lymphadenopathy is due to the trapping of circu- 
ating lymphocytes in the challenged lymph nodes. 
Most of the remaining enlargement can be attributed to proliferation of host 
cells  within the  reacting lymph nodes.  Conditions have been  defined under 
which the weights and p4C]thymidine incorporation of the popliteal nodes can 
be plotted against the dose of injected A/J spleen cells on a double-log scale to 
give a linear dose-response. The popliteal lymph node GVH assay is a simple 
and effective means of quantitating immune reactivity to histocompatibility 
antigens in mice. 
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